RUNX1T1 and acute myeloid leukemia: Both high levels of RUNX1-RUNX1T1 (≥1.58%) on the day of transplantation (day 0) and the ratio of flow cytometric analysis of blasts in bone marrow at first diagnosis increase the chance of t(8;21) AML relapse after allo-HSCT.